Skip to Content

User Reviews for Osimertinib systemic

Also known as: Tagrisso

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Osimertinib

For Non-Small Cell Lung Cancer: " I developed resistance to Erlotinib, which served me well for three years. I now have 4 months with Tagrisso (Osimertinib) and I feel much better, the side effects of diarrhea and rash are more tolerable and showed improvement to the RX"

Alvaro Sanin (taken for 1 to 6 months) September 29, 2017

0 users found this comment helpful.
Did you?   Yes   No   |   Report inappropriate